All Stories

  1. Evidence of aberrant anti-Epstein-Barr virus antibody response, though no viral reactivation, in people with post-stroke fatigue
  2. Cystatin F (Cst7) drives sex-dependent changes in microglia in an amyloid-driven model of Alzheimer’s disease
  3. Treatment with IgM‐enriched intravenous immunoglobulins enhances clearance of stroke‐associated bacterial lung infection
  4. Stroke-induced changes to immune function and their relevance to increased risk of severe COVID-19 disease
  5. Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic
  6. Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence
  7. Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence
  8. Cytokine and Chemokine Concentrations as Biomarkers of Feline Mycobacteriosis
  9. Experimental Stroke Differentially Affects Discrete Subpopulations of Splenic Macrophages
  10. Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke
  11. Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function
  12. Follicular Dendritic Cell-Specific Prion Protein (PrPc) Expression Alone Is Sufficient to Sustain Prion Infection in the Spleen